Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial.
about
Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care.Differences in self-monitored, blood glucose test strip utilization by therapy for type 2 diabetes mellitusPharmacologic treatment of type 2 diabetes: injectable medications.Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLira.Long-term studies of treatments for type 2 diabetes.Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience.
P2860
Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Reduced risk of hypoglycemia w ...... a long-term controlled trial.
@ast
Reduced risk of hypoglycemia w ...... a long-term controlled trial.
@en
type
label
Reduced risk of hypoglycemia w ...... a long-term controlled trial.
@ast
Reduced risk of hypoglycemia w ...... a long-term controlled trial.
@en
prefLabel
Reduced risk of hypoglycemia w ...... a long-term controlled trial.
@ast
Reduced risk of hypoglycemia w ...... a long-term controlled trial.
@en
P2093
P2860
P1476
Reduced risk of hypoglycemia w ...... a long-term controlled trial.
@en
P2093
Marie-Paule Dain
Matthew Riddle
Peter Mullins
Stefan Schinzel
Vivian Fonseca
P2860
P304
P356
10.1016/J.JDIACOMP.2014.04.003
P577
2014-04-16T00:00:00Z